Tesla building RNA microfactories to help fight Covid-19: Musk - San Francisco News
by Maria Thomas
Updated Jul 03, 2020
CureVac's printers are designed to quickly create mRNA vaccine candidates against known pathogens.
"Tesla, as a side project, is building RNA microfactories for CureVac & possibly others," Tesla CEO Elon Musk tweeted on Thursday.
"In principle, I think synthetic RNA (and DNA) has amazing potential. This basically makes the solution to many diseases a software problem," he added.
Pharmaceutical companies like CureVac are working to create a Covid-19 vaccine using "messenger RNA," which can be manually inserted into cells to initiate an immune response.
CureVac says its mRNA vaccine candidates direct cells to make proteins or antigens against various diseases.
CureVac's vaccine candidate called ‘CVnCoV' received German and Belgian regulatory clearance to enter phase 1 human testing last month.
Other companies making RNA vaccines include Moderna and Pfizer and BioNTech.
According to Forbes, Moderna is looking to start phase 3 trials by July for its vaccine candidate named mRNA-1273.
BioNTech is developing the vaccine inside of China with Fosun Pharma, a Chinese pharmaceutical company, and Pfizer said they will develop the company's experimental Covid-19 vaccine outside of China.
Related Articles
- Optical Illusion Brain Test: If you have Sharp Eyes Find the Number 442 in 20 Secs
- London-based firm Nothing to release its Phone (2)
- Covid will continue to cause mini-waves, not become seasonal yet: Scientists
- Hackers offering crypto accounts for as low as $30 on darknet
- Reddit's new feature to allow users to share its content on other platforms
- Surgical masks can help kids fight respiratory infections: Study
- LinkedIn's new AI feature to write messages to hiring team
- Microsoft introduces Xbox Game Pass' new Friend Referral programme
- Disbursed over Rs 31 cr in claims to delivery partners in FY22-23: Swiggy
- India emerging as favourable destination for clinical trials: Report
